查詢結果分析
相關文獻
頁籤選單縮合
題 名 | Association of Warfarin with Congestive Heart Failure and Peripheral Artery Occlusive Disease in Hemodialysis Patients with Atrial Fibrillation |
---|---|
作 者 | Lee, Kuo-hua; Li, Szu-yuan; Liu, Jin-sin; Huang, Chi-ting; Chen, Ying-ying; Lin, Yao-ping; Hsu, Chih-cheng; Tarng, Der-cherng; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 80:5 2017.05[民106.05] |
頁 次 | 頁277-282 |
分類號 | 418.2321 |
關鍵詞 | Atrial fibrillation; Hemodialysis; Warfarin; |
語 文 | 英文(English) |
英文摘要 | Background The effect of warfarin on the risk of cardiovascular (CV) disease is unknown among chronic hemodialysis patients with atrial fibrillation (HD-AF). Methods Population-based propensity score and prescription time-distribution matched cohort study including 6719 HD-AF patients with CHA 2 DS 2 -VASc score ≥ 2 were divided into warfarin users and nonusers and followed-up for CV events and death. Results Warfarin treatment in HD-AF patients with AF preceding HD was associated with higher risks of developing congestive heart failure [hazard ratio (HR) = 1.82, 95% confidence interval (CI) = 1.29–2.58, p < 0.01], peripheral artery occlusive disease (HR = 3.42, 95% CI = 1.86–6.31, p < 0.01), and aortic valve stenosis (HR = 3.20, 95% CI = 1.02–9.98, p < 0.05). Warfarin users were not associated with risks of ischemic or hemorrhagic stroke and all-cause mortality as compared to nonusers. Conclusion Warfarin may be associated with vascular calcification, increasing the risks of congestive heart failure and peripheral artery occlusive disease among HD-AF patients. |
本系統中英文摘要資訊取自各篇刊載內容。